Cargando…

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer

BACKGROUND: Detection of HER2/neu receptor overexpression and/or amplification is a prerequisite for efficient anti-HER2 treatment of breast and gastric carcinomas. Immunohistochemistry (IHC) of the HER2 protein is the most common screening test, thus precise and reproducible IHC-scoring is of utmos...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheel, Andreas H., Penault-Llorca, Frédérique, Hanna, Wedad, Baretton, Gustavo, Middel, Peter, Burchhardt, Judith, Hofmann, Manfred, Jasani, Bharat, Rüschoff, Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848460/
https://www.ncbi.nlm.nih.gov/pubmed/29530054
http://dx.doi.org/10.1186/s13000-018-0696-x
_version_ 1783305880807145472
author Scheel, Andreas H.
Penault-Llorca, Frédérique
Hanna, Wedad
Baretton, Gustavo
Middel, Peter
Burchhardt, Judith
Hofmann, Manfred
Jasani, Bharat
Rüschoff, Josef
author_facet Scheel, Andreas H.
Penault-Llorca, Frédérique
Hanna, Wedad
Baretton, Gustavo
Middel, Peter
Burchhardt, Judith
Hofmann, Manfred
Jasani, Bharat
Rüschoff, Josef
author_sort Scheel, Andreas H.
collection PubMed
description BACKGROUND: Detection of HER2/neu receptor overexpression and/or amplification is a prerequisite for efficient anti-HER2 treatment of breast and gastric carcinomas. Immunohistochemistry (IHC) of the HER2 protein is the most common screening test, thus precise and reproducible IHC-scoring is of utmost importance. Interobserver variance still is a problem; in particular in gastric carcinomas the reliable differentiation of IHC scores 2+ and 1+ is challenging. Herein we describe the physical basis of what we called the ‘magnification rule’: Different microscope objectives are employed to reproducibly subdivide the continuous spectrum of IHC staining intensities into distinct categories (1+, 2+, 3+). METHODS: HER2-IHC was performed on 120 breast cancer biopsy specimens (n = 40 per category). Width and color-intensity of membranous DAB chromogen precipitates were measured by whole-slide scanning and digital morphometry. Image-analysis data were related to semi-quantitative manual scoring according to the magnification rule and to the optical properties of the employed microscope objectives. RESULTS: The semi-quantitative manual HER2-IHC scores are correlated to color-intensity measured by image-analysis and to the width of DAB-precipitates. The mean widths ±standard deviations of precipitates were: IHC-score 1+, 0.64 ± 0.1 μm; score 2+, 1.0 ± 0.23 μm; score 3+, 2.14 ± 0.4 μm. The width of precipitates per category matched the optical resolution of the employed microscope objective lenses: Approximately 0.4 μm (40×), 1.0 μm (10×) and 2.0 μm (5×). CONCLUSIONS: Perceived intensity, width of the DAB chromogen precipitate, and absolute color-intensity determined by image-analysis are linked. These interrelations form the physical basis of the ‘magnification rule’: 2+ precipitates are too narrow to be observed with 5× microscope objectives, 1+ precipitates are too narrow for 10× objectives. Thus, the rule uses the optical resolution windows of standard diagnostic microscope objectives to derive the width of the DAB-precipitates. The width is in turn correlated with color-intensity. Hereby, the more or less subjective estimation of IHC scores based only on the staining-intensity is replaced by a quasi-morphometric measurement. The principle seems universally applicable to immunohistochemical stainings of membrane-bound biomarkers that require an intensity-dependent scoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13000-018-0696-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5848460
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58484602018-03-21 Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer Scheel, Andreas H. Penault-Llorca, Frédérique Hanna, Wedad Baretton, Gustavo Middel, Peter Burchhardt, Judith Hofmann, Manfred Jasani, Bharat Rüschoff, Josef Diagn Pathol Research BACKGROUND: Detection of HER2/neu receptor overexpression and/or amplification is a prerequisite for efficient anti-HER2 treatment of breast and gastric carcinomas. Immunohistochemistry (IHC) of the HER2 protein is the most common screening test, thus precise and reproducible IHC-scoring is of utmost importance. Interobserver variance still is a problem; in particular in gastric carcinomas the reliable differentiation of IHC scores 2+ and 1+ is challenging. Herein we describe the physical basis of what we called the ‘magnification rule’: Different microscope objectives are employed to reproducibly subdivide the continuous spectrum of IHC staining intensities into distinct categories (1+, 2+, 3+). METHODS: HER2-IHC was performed on 120 breast cancer biopsy specimens (n = 40 per category). Width and color-intensity of membranous DAB chromogen precipitates were measured by whole-slide scanning and digital morphometry. Image-analysis data were related to semi-quantitative manual scoring according to the magnification rule and to the optical properties of the employed microscope objectives. RESULTS: The semi-quantitative manual HER2-IHC scores are correlated to color-intensity measured by image-analysis and to the width of DAB-precipitates. The mean widths ±standard deviations of precipitates were: IHC-score 1+, 0.64 ± 0.1 μm; score 2+, 1.0 ± 0.23 μm; score 3+, 2.14 ± 0.4 μm. The width of precipitates per category matched the optical resolution of the employed microscope objective lenses: Approximately 0.4 μm (40×), 1.0 μm (10×) and 2.0 μm (5×). CONCLUSIONS: Perceived intensity, width of the DAB chromogen precipitate, and absolute color-intensity determined by image-analysis are linked. These interrelations form the physical basis of the ‘magnification rule’: 2+ precipitates are too narrow to be observed with 5× microscope objectives, 1+ precipitates are too narrow for 10× objectives. Thus, the rule uses the optical resolution windows of standard diagnostic microscope objectives to derive the width of the DAB-precipitates. The width is in turn correlated with color-intensity. Hereby, the more or less subjective estimation of IHC scores based only on the staining-intensity is replaced by a quasi-morphometric measurement. The principle seems universally applicable to immunohistochemical stainings of membrane-bound biomarkers that require an intensity-dependent scoring. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13000-018-0696-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-12 /pmc/articles/PMC5848460/ /pubmed/29530054 http://dx.doi.org/10.1186/s13000-018-0696-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Scheel, Andreas H.
Penault-Llorca, Frédérique
Hanna, Wedad
Baretton, Gustavo
Middel, Peter
Burchhardt, Judith
Hofmann, Manfred
Jasani, Bharat
Rüschoff, Josef
Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title_full Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title_fullStr Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title_full_unstemmed Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title_short Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
title_sort physical basis of the ‘magnification rule’ for standardized immunohistochemical scoring of her2 in breast and gastric cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848460/
https://www.ncbi.nlm.nih.gov/pubmed/29530054
http://dx.doi.org/10.1186/s13000-018-0696-x
work_keys_str_mv AT scheelandreash physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT penaultllorcafrederique physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT hannawedad physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT barettongustavo physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT middelpeter physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT burchhardtjudith physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT hofmannmanfred physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT jasanibharat physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer
AT ruschoffjosef physicalbasisofthemagnificationruleforstandardizedimmunohistochemicalscoringofher2inbreastandgastriccancer